TD Securities Forecasts Strong Price Appreciation for Extendicare (TSE:EXE) Stock

Extendicare (TSE:EXEGet Free Report) had its price target hoisted by equities research analysts at TD Securities from C$13.00 to C$15.00 in a research report issued on Thursday,BayStreet.CA reports. The brokerage currently has a “hold” rating on the stock. TD Securities’ price objective points to a potential upside of 4.82% from the company’s current price.

EXE has been the subject of a number of other research reports. BMO Capital Markets boosted their target price on shares of Extendicare from C$13.50 to C$14.50 in a research note on Monday, May 12th. Cormark upgraded shares of Extendicare to a “moderate buy” rating in a research note on Wednesday, February 19th.

Check Out Our Latest Report on EXE

Extendicare Stock Performance

TSE:EXE opened at C$14.31 on Thursday. The company has a fifty day simple moving average of C$13.54 and a two-hundred day simple moving average of C$11.75. The company has a market cap of C$1.19 billion, a price-to-earnings ratio of 18.25 and a beta of 1.26. The company has a quick ratio of 0.98, a current ratio of 0.62 and a debt-to-equity ratio of 283.02. Extendicare has a 52 week low of C$7.10 and a 52 week high of C$15.24.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Further Reading

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.